Zoetis Inc (ZTS) stock news · P/E 13, rev $9.47B
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
This ZTS news page leads with what Zoetis Inc filed — not a scraped headline mill.
No cached 8-K sentence for ZTS yet. We will not pad this page with generic market recap.
Latest reported ZTS revenue for 2025-12-31 was $9.47B. Net income was $2.67B. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. ZTS currently screens at market cap $64.65B and trailing P/E 13.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZTS stock page; for the tape open the quote page.
ZTS stock news FAQ
What are ZTS's latest revenue and net income?
Latest cached Zoetis Inc (ZTS) revenue for Dec 31, 2025 was $9.47B. Net income was $2.67B. Statements: https://lician.com/financials/zts
How did ZTS revenue change from the prior cached period?
Cached Zoetis Inc (ZTS) revenue was up 2.3% from $9.26B (Dec 31, 2024) to $9.47B (Dec 31, 2025). Statements: https://lician.com/financials/zts
What is ZTS's P/E ratio?
Zoetis Inc (ZTS) trailing P/E is 13.3 on the latest cached fundamentals snapshot.
What is ZTS's market cap?
Zoetis Inc (ZTS) market cap is $64.65B on the latest cached fundamentals snapshot.
What kind of company is ZTS?
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Where is ZTS stock news listed?
Cached stock news for Zoetis Inc (ZTS) is listed at https://lician.com/news/zts. Filings: https://lician.com/sec/zts
Not investment advice.